Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.

Journal article

Wellens J. et al, (2023), Inflammatory bowel diseases

Editorial: in search of environmental risk factors of Crohn's disease and ulcerative colitis with mendelian randomisation-authors' reply.

Journal article

Chen J. et al, (2023), Alimentary pharmacology & therapeutics, 57, 1034 - 1035

Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease

Journal article

Shubhakar A. et al, (2023), Journal of Crohn's and Colitis

Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapy.

Journal article

Chauhan D. et al, (2023), Frontline gastroenterology, 14, 432 - 434

Long-term temporal stability of peripheral blood DNA methylation profiles in patients with inflammatory bowel disease.

Journal article

Joustra V. et al, (2022), Cellular and molecular gastroenterology and hepatology

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy.

Journal article

Selim R. et al, (2022), The lancet. Gastroenterology & hepatology

Load More